PAFAH1B2 Antibodies

Santa Cruz Biotechnology delivers a wide array of PAFAH1B2 monoclonal antibodies for research applications. PAFAH1B2 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PAFAH1B2, also known as platelet-activating factor acetylhydrolase 1b, is crucial for lipid metabolism and plays a significant role in the regulation of inflammatory responses. By hydrolyzing platelet-activating factor (PAF), PAFAH1B2 helps modulate cellular signaling pathways, making it essential for maintaining cellular homeostasis and responding to stress. Understanding the function of PAFAH1B2 is vital for elucidating its involvement in various physiological and pathological processes. PAFAH1B2 research has revealed important insights into cellular metabolism and inflammatory regulation. Ongoing studies continue to uncover new roles for PAFAH1B2 in health and disease mechanisms. Research utilizing PAFAH1B2 monoclonal antibodies has advanced our understanding of cellular pathways and molecular interactions. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific knowledge and developing potential therapeutic strategies.